{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:00:47Z","timestamp":1793638847116,"version":"4.5.1"},"reference-count":177,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr. Diabetes"],"DOI":"10.1038\/s41387-026-00431-z","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T01:58:41Z","timestamp":1780538321000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Interplay between sarcopenia and type 2 diabetes: mechanisms, implications, and therapeutic prospects"],"prefix":"10.1038","volume":"16","author":[{"given":"Mrinmoy","family":"Ghosh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunji","family":"Heo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gajraj Singh","family":"Kushwaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanmi","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0154-4061","authenticated-orcid":false,"given":"Young-Ok","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"key":"431_CR1","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1177\/1479972316679664","volume":"14","author":"AE Bone","year":"2017","unstructured":"Bone AE, Hepgul N, Kon S, Maddocks M. Sarcopenia and frailty in chronic respiratory disease. Chron Respir Dis. 2017;14:85\u201399.","journal-title":"Chron Respir Dis"},{"key":"431_CR2","doi-asserted-by":"crossref","unstructured":"Papadopoulou SK. Sarcopenia: a contemporary health problem among older adult populations. Nutrients. 2020;12:1293.","DOI":"10.3390\/nu12051293"},{"key":"431_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2023.102835","volume":"17","author":"A Marcotte-Ch\u00e9nard","year":"2023","unstructured":"Marcotte-Ch\u00e9nard A, Oliveira B, Little JP, Candow DG. Sarcopenia and type 2 diabetes: pathophysiology and potential therapeutic lifestyle interventions. Diab Metab Syndr. 2023;17:102835.","journal-title":"Diab Metab Syndr"},{"key":"431_CR4","doi-asserted-by":"publisher","first-page":"964","DOI":"10.3390\/nu16070964","volume":"16","author":"S Kim","year":"2024","unstructured":"Kim S, Kim S, Hong KH. Association of combining diet and physical activity on sarcopenia and obesity in elderly koreans with diabetes. Nutrients. 2024;16:964.","journal-title":"Nutrients"},{"key":"431_CR5","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/j.2040-4603.2020.tb00136.x","volume":"10","author":"KE Merz","year":"2020","unstructured":"Merz KE, Thurmond DC. Role of skeletal muscle in insulin resistance and glucose uptake. Compr Physiol. 2020;10:785\u2013809.","journal-title":"Compr Physiol"},{"key":"431_CR6","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S1566-0702(01)00368-X","volume":"96","author":"B Ulfhak","year":"2002","unstructured":"Ulfhak B, Bergman E, Fundin BT. Impairment of peripheral sensory innervation in senescence. Auton Neurosci. 2002;96:43\u20139.","journal-title":"Auton Neurosci"},{"key":"431_CR7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1093\/gerona\/glad029","volume":"78","author":"BC Clark","year":"2023","unstructured":"Clark BC. Neural mechanisms of age-related loss of muscle performance and physical function. J Gerontol. Ser A. 2023;78:8\u201313.","journal-title":"J Gerontol. Ser A"},{"key":"431_CR8","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1002\/art.21267","volume":"52","author":"G Zhai","year":"2005","unstructured":"Zhai G, Ding C, Stankovich J, Cicuttini F, Jones G. The genetic contribution to longitudinal changes in knee structure and muscle strength: a sibpair study. Arthritis Rheum. 2005;52:2830\u20134.","journal-title":"Arthritis Rheum"},{"key":"431_CR9","doi-asserted-by":"publisher","first-page":"801","DOI":"10.14336\/AD.2021.1107","volume":"13","author":"Q Yang","year":"2022","unstructured":"Yang Q, Chan P. Skeletal muscle metabolic alternation develops sarcopenia. Aging Dis. 2022;13:801\u201314.","journal-title":"Aging Dis"},{"key":"431_CR10","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1093\/hmg\/ddv613","volume":"25","author":"MW Hogarth","year":"2016","unstructured":"Hogarth MW, Garton FC, Houweling PJ, Tukiainen T, Lek M, Macarthur DG, et al. Analysis of the ACTN3 heterozygous genotype suggests that \u03b1-actinin-3 controls sarcomeric composition and muscle function in a dose-dependent fashion. Hum Mol Genet. 2016;25:866\u201377.","journal-title":"Hum Mol Genet"},{"key":"431_CR11","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.molcel.2016.01.028","volume":"61","author":"N Sun","year":"2016","unstructured":"Sun N, Youle RJ, Finkel T. The mitochondrial basis of aging. Mol Cell. 2016;61:654\u201366.","journal-title":"Mol Cell"},{"key":"431_CR12","doi-asserted-by":"crossref","unstructured":"Baczek J, Silkiewicz M, Wojszel ZB. Myostatin as a biomarker of muscle wasting and other pathologies-state of the art and knowledge gaps. Nutrients. 2020;12:2401.","DOI":"10.3390\/nu12082401"},{"key":"431_CR13","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.steroids.2016.08.009","volume":"115","author":"JG Mouser","year":"2016","unstructured":"Mouser JG, Loprinzi PD, Loenneke JP. The association between physiologic testosterone levels, lean mass, and fat mass in a nationally representative sample of men in the United States. Steroids. 2016;115:62\u20136.","journal-title":"Steroids"},{"key":"431_CR14","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/805172","volume":"2015","author":"D Costamagna","year":"2015","unstructured":"Costamagna D, Costelli P, Sampaolesi M, Penna F. Role of inflammation in muscle homeostasis and myogenesis. Mediat Inflamm. 2015;2015:805172.","journal-title":"Mediat Inflamm"},{"key":"431_CR15","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1126\/science.285.5432.1390","volume":"285","author":"CK Lee","year":"1999","unstructured":"Lee CK, Klopp RG, Weindruch R, Prolla TA. Gene expression profile of aging and its retardation by caloric restriction. Science. 1999;285:1390\u20133.","journal-title":"Science"},{"key":"431_CR16","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1126\/science.1118357","volume":"310","author":"D Chen","year":"2005","unstructured":"Chen D, Steele AD, Lindquist S, Guarente L. Increase in activity during calorie restriction requires Sirt1. Science. 2005;310:1641.","journal-title":"Science"},{"key":"431_CR17","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.2147\/DMSO.S410834","volume":"16","author":"H Chen","year":"2023","unstructured":"Chen H, Huang X, Dong M, Wen S, Zhou L, Yuan X. The association between sarcopenia and diabetes: from pathophysiology mechanism to therapeutic strategy. Diab Metab Syndr Obes. 2023;16:1541\u201354.","journal-title":"Diab Metab Syndr Obes"},{"key":"431_CR18","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1093\/hmg\/ddm380","volume":"17","author":"DG MacArthur","year":"2008","unstructured":"MacArthur DG, Seto JT, Chan S, Quinlan KG, Raftery JM, Turner N, et al. An Actn3 knockout mouse provides mechanistic insights into the association between alpha-actinin-3 deficiency and human athletic performance. Hum Mol Genet. 2008;17:1076\u201386.","journal-title":"Hum Mol Genet"},{"key":"431_CR19","doi-asserted-by":"publisher","first-page":"3310","DOI":"10.1210\/jc.2014-1124","volume":"99","author":"B Hsu","year":"2014","unstructured":"Hsu B, Cumming RG, Naganathan V, Blyth FM, Le Couteur DG, Seibel MJ, et al. Longitudinal relationships of circulating reproductive hormone with functional disability, muscle mass, and strength in community-dwelling older men: the Concord Health and Ageing in Men project. J Clin Endocrinol Metab. 2014;99:3310\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"431_CR20","doi-asserted-by":"crossref","unstructured":"Curcio F, Testa G, Liguori I, Papillo M, Flocco V, Panicara V, et al. Sarcopenia and heart failure. Nutrients. 2020;12:211.","DOI":"10.3390\/nu12010211"},{"key":"431_CR21","doi-asserted-by":"crossref","unstructured":"Engel AG. Chapter 3\u2014The neuromuscular junction. Handbook of clinical neurology. 91: Elsevier; 2008. p. 103\u201348.","DOI":"10.1016\/S0072-9752(07)01503-5"},{"key":"431_CR22","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13098-020-0523-x","volume":"12","author":"J Shou","year":"2020","unstructured":"Shou J, Chen PJ, Xiao WH. Mechanism of increased risk of insulin resistance in aging skeletal muscle. Diabetol Metab Syndr. 2020;12:14.","journal-title":"Diabetol Metab Syndr"},{"key":"431_CR23","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/jcsm.12411","volume":"10","author":"SSY Yeung","year":"2019","unstructured":"Yeung SSY, Reijnierse EM, Pham VK, Trappenburg MC, Lim WK, Meskers CGM, et al. Sarcopenia and its association with falls and fractures in older adults: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2019;10:485\u2013500.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"431_CR24","doi-asserted-by":"publisher","first-page":"95","DOI":"10.4137\/BMI.S38440","volume":"11","author":"SI Sherwani","year":"2016","unstructured":"Sherwani SI, Khan HA, Ekhzaimy A, Masood A, Sakharkar MK. Significance of HbA1c test in diagnosis and prognosis of diabetic patients. Biomark Insights. 2016;11:95\u2013104.","journal-title":"Biomark Insights"},{"key":"431_CR25","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00223-020-00742-y","volume":"107","author":"P Anagnostis","year":"2020","unstructured":"Anagnostis P, Gkekas NK, Achilla C, Pananastasiou G, Taouxidou P, Mitsiou M, et al. Type 2 diabetes mellitus is associated with increased risk of sarcopenia: a systematic review and meta-analysis. Calcif Tissue Int. 2020;107:453\u201363.","journal-title":"Calcif Tissue Int"},{"key":"431_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2021.107926","volume":"35","author":"Y Lin","year":"2021","unstructured":"Lin Y, Zhang Y, Shen X, Huang L, Yan S. Influence of glucose, insulin fluctuation, and glycosylated hemoglobin on the outcome of sarcopenia in patients with type 2 diabetes mellitus. J Diab Complicat. 2021;35:107926.","journal-title":"J Diab Complicat"},{"key":"431_CR27","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1111\/jdi.13014","volume":"10","author":"H Mori","year":"2019","unstructured":"Mori H, Kuroda A, Ishizu M, Ohishi M, Takashi Y, Otsuka Y, et al. Association of accumulated advanced glycation end-products with a high prevalence of sarcopenia and dynapenia in patients with type 2 diabetes. J Diab Investig. 2019;10:1332\u201340.","journal-title":"J Diab Investig"},{"key":"431_CR28","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.jamda.2016.07.007","volume":"17","author":"A Liccini","year":"2016","unstructured":"Liccini A, Malmstrom TK. Frailty and sarcopenia as predictors of adverse health outcomes in persons with diabetes mellitus. J Am Med Dir Assoc. 2016;17:846\u201351.","journal-title":"J Am Med Dir Assoc"},{"key":"431_CR29","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12877-019-1137-8","volume":"19","author":"FY Fung","year":"2019","unstructured":"Fung FY, Koh YLE, Malhotra R, Ostbye T, Lee PY, Shariff Ghazali S, et al. Prevalence of and factors associated with sarcopenia among multi-ethnic ambulatory older Asians with type 2 diabetes mellitus in a primary care setting. BMC Geriatr. 2019;19:122.","journal-title":"BMC Geriatr"},{"key":"431_CR30","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s00125-016-4196-9","volume":"60","author":"JW Son","year":"2017","unstructured":"Son JW, Lee SS, Kim SR, Yoo SJ, Cha BY, Son HY, et al. Low muscle mass and risk of type 2 diabetes in middle-aged and older adults: findings from the KoGES. Diabetologia. 2017;60:865\u201372.","journal-title":"Diabetologia"},{"key":"431_CR31","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1111\/jdi.13752","volume":"13","author":"CY Wen","year":"2022","unstructured":"Wen CY, Lien AS, Jiang YD. Sarcopenia in elderly diabetes. J Diab Investig. 2022;13:944\u20136.","journal-title":"J Diab Investig"},{"key":"431_CR32","doi-asserted-by":"publisher","first-page":"e0265221","DOI":"10.1371\/journal.pone.0265221","volume":"17","author":"S Huang","year":"2022","unstructured":"Huang S, Xiang C, Song Y. Identification of the shared gene signatures and pathways between sarcopenia and type 2 diabetes mellitus. PloS one. 2022;17:e0265221.","journal-title":"PloS one"},{"key":"431_CR33","doi-asserted-by":"crossref","unstructured":"Lin JA, Hou JD, Wu SY. Effect of sarcopenia on mortality in type 2 diabetes: a long-term follow-up propensity score-matched diabetes cohort study. J Clin Med. 2022;11:4424.","DOI":"10.3390\/jcm11154424"},{"key":"431_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.869011","volume":"10","author":"S Ghafouri-Fard","year":"2022","unstructured":"Ghafouri-Fard S, Khoshbakht T, Hussen BM, Baniahmad A, Branicki W, Taheri M, et al. Emerging role of non-coding RNAs in senescence. Front Cell Dev Biol. 2022;10:869011.","journal-title":"Front Cell Dev Biol"},{"key":"431_CR35","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1093\/ajcn\/81.5.953","volume":"81","author":"KS Nair","year":"2005","unstructured":"Nair KS. Aging muscle. Am J Clin Nutr. 2005;81:953\u201363.","journal-title":"Am J Clin Nutr"},{"key":"431_CR36","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3389\/fphys.2012.00260","volume":"3","author":"WK Mitchell","year":"2012","unstructured":"Mitchell WK, Williams J, Atherton P, Larvin M, Lund J, Narici M. Sarcopenia, dynapenia, and the impact of advancing age on human skeletal muscle size and strength; a quantitative review. Front Physiol. 2012;3:260.","journal-title":"Front Physiol"},{"key":"431_CR37","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1556\/650.2021.32015","volume":"162","author":"A P\u00e1r","year":"2021","unstructured":"P\u00e1r A, Hegyi JP, V\u00e1ncsa S, P\u00e1r G. Sarcopenia\u20142021: pathophysiology, diagnosis, therapy]. Orv Hetil. 2021;162:3\u201312.","journal-title":"Orv Hetil"},{"key":"431_CR38","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","volume":"48","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruy\u00e8re O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48:16\u201331.","journal-title":"Age Ageing"},{"key":"431_CR39","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.2337\/db05-1183","volume":"55","author":"SW Park","year":"2006","unstructured":"Park SW, Goodpaster BH, Strotmeyer ES, de Rekeneire N, Harris TB, Schwartz AV, et al. Decreased muscle strength and quality in older adults with type 2 diabetes: the health, aging, and body composition study. Diabetes. 2006;55:1813\u20138.","journal-title":"Diabetes"},{"key":"431_CR40","doi-asserted-by":"publisher","first-page":"e0116206","DOI":"10.1371\/journal.pone.0116206","volume":"10","author":"MJ Proctor","year":"2015","unstructured":"Proctor MJ, McMillan DC, Horgan PG, Fletcher CD, Talwar D, Morrison DS. Systemic inflammation predicts all-cause mortality: a Glasgow inflammation outcome study. PloS one. 2015;10:e0116206.","journal-title":"PloS one"},{"key":"431_CR41","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.1210\/jc.2006-0357","volume":"91","author":"I Sinha-Hikim","year":"2006","unstructured":"Sinha-Hikim I, Cornford M, Gaytan H, Lee ML, Bhasin S. Effects of testosterone supplementation on skeletal muscle fiber hypertrophy and satellite cells in community-dwelling older men. J Clin Endocrinol Metab. 2006;91:3024\u201333.","journal-title":"J Clin Endocrinol Metab"},{"key":"431_CR42","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1007\/s40520-019-01371-8","volume":"32","author":"NF Meier","year":"2020","unstructured":"Meier NF, Lee DC. Physical activity and sarcopenia in older adults. Aging Clin Exp Res. 2020;32:1675\u201387.","journal-title":"Aging Clin Exp Res"},{"key":"431_CR43","doi-asserted-by":"crossref","unstructured":"Dang M, Shore-Lorenti C, McMillan LB, Mesinovic J, Hayes A, Ebeling PR, et al. Associations of serum 25-hydroxyvitamin d with physical performance and bone health in overweight and obese older adults. Int J Environ Res Public Health. 2019;16:509.","DOI":"10.3390\/ijerph16030509"},{"key":"431_CR44","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.trsl.2017.02.004","volume":"184","author":"J Maddatu","year":"2017","unstructured":"Maddatu J, Anderson-Baucum E, Evans-Molina C. Smoking and the risk of type 2 diabetes. Transl Res. 2017;184:101\u20137.","journal-title":"Transl Res"},{"key":"431_CR45","doi-asserted-by":"crossref","unstructured":"Argyropoulou D, Geladas ND, Nomikos T, Paschalis V. Exercise and nutrition strategies for combating sarcopenia and type 2 diabetes mellitus in older adults. J Funct Morphol Kinesiol. 2022;7:48.","DOI":"10.3390\/jfmk7020048"},{"key":"431_CR46","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.yexcr.2013.12.011","volume":"322","author":"R Stall","year":"2014","unstructured":"Stall R, Ramos J, Kent Fulcher F, Patel YM. Regulation of myosin IIA and filamentous actin during insulin-stimulated glucose uptake in 3T3-L1 adipocytes. Exp Cell Res. 2014;322:81\u20138.","journal-title":"Exp Cell Res"},{"key":"431_CR47","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/476279","volume":"2010","author":"MA Abdul-Ghani","year":"2010","unstructured":"Abdul-Ghani MA, DeFronzo RA. Pathogenesis of insulin resistance in skeletal muscle. J Biomed Biotechnol. 2010;2010:476279.","journal-title":"J Biomed Biotechnol"},{"key":"431_CR48","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s00592-022-01883-2","volume":"59","author":"HA Giha","year":"2022","unstructured":"Giha HA, Alamin OAO, Sater MS. Diabetic sarcopenia: metabolic and molecular appraisal. Acta Diabetol. 2022;59:989\u20131000.","journal-title":"Acta Diabetol"},{"key":"431_CR49","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.yexcr.2008.10.002","volume":"315","author":"ST Russell","year":"2009","unstructured":"Russell ST, Rajani S, Dhadda RS, Tisdale MJ. Mechanism of induction of muscle protein loss by hyperglycaemia. Exp Cell Res. 2009;315:16\u201325.","journal-title":"Exp Cell Res"},{"key":"431_CR50","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1900\/RDS.2022.18.157","volume":"18","author":"D Purnamasari","year":"2022","unstructured":"Purnamasari D, Tetrasiwi EN, Kartiko GJ, Astrella C, Husam K, Laksmi PW. Sarcopenia and chronic complications of type 2 diabetes mellitus. Rev Diabet Stud. 2022;18:157\u201365.","journal-title":"Rev Diabet Stud"},{"key":"431_CR51","doi-asserted-by":"crossref","unstructured":"Hirata Y, Nomura K, Senga Y, Okada Y, Kobayashi K, Okamoto S, et al. Hyperglycemia induces skeletal muscle atrophy via a WWP1\/KLF15 axis. JCI Insight. 2019;4:e124952.","DOI":"10.1172\/jci.insight.124952"},{"key":"431_CR52","doi-asserted-by":"publisher","first-page":"E222","DOI":"10.1152\/ajpendo.00060.2017","volume":"313","author":"MJ McBride","year":"2017","unstructured":"McBride MJ, Foley KP, D\u2019Souza DM, Li YE, Lau TC, Hawke TJ, et al. The NLRP3 inflammasome contributes to sarcopenia and lower muscle glycolytic potential in old mice. Am J Physiol Endocrinol Metab. 2017;313:E222\u2013e32.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"431_CR53","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.jhep.2016.07.040","volume":"65","author":"S Dasarathy","year":"2016","unstructured":"Dasarathy S, Merli M. Sarcopenia from mechanism to diagnosis and treatment in liver disease. J Hepatol. 2016;65:1232\u201344.","journal-title":"J Hepatol"},{"key":"431_CR54","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.exger.2016.01.008","volume":"76","author":"A Buch","year":"2016","unstructured":"Buch A, Carmeli E, Boker LK, Marcus Y, Shefer G, Kis O, et al. Muscle function and fat content in relation to sarcopenia, obesity and frailty of old age\u2014an overview. Exp Gerontol. 2016;76:25\u201332.","journal-title":"Exp Gerontol"},{"key":"431_CR55","first-page":"94","volume":"22","author":"BD Perry","year":"2016","unstructured":"Perry BD, Caldow MK, Brennan-Speranza TC, Sbaraglia M, Jerums G, Garnham A, et al. Muscle atrophy in patients with Type 2 Diabetes Mellitus: roles of inflammatory pathways, physical activity and exercise. Exerc Immunol Rev. 2016;22:94\u2013109.","journal-title":"Exerc Immunol Rev"},{"key":"431_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2022.111823","volume":"164","author":"X Zhang","year":"2022","unstructured":"Zhang X, Li H, He M, Wang J, Wu Y, Li Y. Immune system and sarcopenia: presented relationship and future perspective. Exp Gerontol. 2022;164:111823.","journal-title":"Exp Gerontol"},{"key":"431_CR57","doi-asserted-by":"publisher","first-page":"180","DOI":"10.4103\/1947-2714.94944","volume":"4","author":"R Goyal","year":"2012","unstructured":"Goyal R, Faizy AF, Siddiqui SS, Singhai M. Evaluation of TNF-\u03b1 and IL-6 levels in obese and non-obese diabetics: pre- and postinsulin effects. N Am J Med Sci. 2012;4:180\u20134.","journal-title":"N Am J Med Sci"},{"key":"431_CR58","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/oby.2001.54","volume":"9","author":"B Vozarova","year":"2001","unstructured":"Vozarova B, Weyer C, Hanson K, Tataranni PA, Bogardus C, Pratley RE. Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes Res. 2001;9:414\u20137.","journal-title":"Obes Res"},{"key":"431_CR59","doi-asserted-by":"publisher","first-page":"M326","DOI":"10.1093\/gerona\/57.5.M326","volume":"57","author":"M Visser","year":"2002","unstructured":"Visser M, Pahor M, Taaffe DR, Goodpaster BH, Simonsick EM, Newman AB, et al. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol A Biol Sci Med Sci. 2002;57:M326\u201332.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"431_CR60","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s12877-018-1007-9","volume":"18","author":"YD Rong","year":"2018","unstructured":"Rong YD, Bian AL, Hu HY, Ma Y, Zhou XZ. Study on relationship between elderly sarcopenia and inflammatory cytokine IL-6, anti-inflammatory cytokine IL-10. BMC Geriatr. 2018;18:308.","journal-title":"BMC Geriatr"},{"key":"431_CR61","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.2337\/dc06-2537","volume":"30","author":"SW Park","year":"2007","unstructured":"Park SW, Goodpaster BH, Strotmeyer ES, Kuller LH, Broudeau R, Kammerer C, et al. Accelerated loss of skeletal muscle strength in older adults with type 2 diabetes: the health, aging, and body composition study. Diab Care. 2007;30:1507\u201312.","journal-title":"Diab Care"},{"key":"431_CR62","doi-asserted-by":"publisher","first-page":"622","DOI":"10.15252\/emmm.201607052","volume":"9","author":"JF Ma","year":"2017","unstructured":"Ma JF, Sanchez BJ, Hall DT, Tremblay AK, Di Marco S, Gallouzi IE. STAT3 promotes IFN\u03b3\/TNF\u03b1-induced muscle wasting in an NF-\u03baB-dependent and IL-6-independent manner. EMBO Mol Med. 2017;9:622\u201337.","journal-title":"EMBO Mol Med"},{"key":"431_CR63","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1126\/science.aal3535","volume":"356","author":"WKE Ip","year":"2017","unstructured":"Ip WKE, Hoshi N, Shouval DS, Snapper S, Medzhitov R. Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages. Science. 2017;356:513\u20139.","journal-title":"Science"},{"key":"431_CR64","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.2147\/DMSO.S186600","volume":"12","author":"J Mesinovic","year":"2019","unstructured":"Mesinovic J, Zengin A, De Courten B, Ebeling PR, Scott D. Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship. Diab Metab Syndr Obes. 2019;12:1057\u201372.","journal-title":"Diab Metab Syndr Obes"},{"key":"431_CR65","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.nutos.2021.11.006","volume":"41","author":"MV Beretta","year":"2022","unstructured":"Beretta MV, Feldman JV, da Silva CN, da Costa Rodrigues T. Association of Subjective Global Assessment and Adductor pollicis muscle thickness with the Sarcopenia in older patients with type 2 diabetes. Clin Nutr Open Sci. 2022;41:62\u201373.","journal-title":"Clin Nutr Open Sci"},{"key":"431_CR66","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1016\/j.clnu.2018.04.018","volume":"37","author":"R Barazzoni","year":"2018","unstructured":"Barazzoni R, Bischoff SC, Boirie Y, Busetto L, Cederholm T, Dicker D, et al. Sarcopenic obesity: time to meet the challenge. Clin Nutr. 2018;37:1787\u201393.","journal-title":"Clin Nutr"},{"key":"431_CR67","doi-asserted-by":"crossref","unstructured":"Beaudart C, Sanchez-Rodriguez D, Locquet M, Reginster JY, Lengel\u00e9 L, Bruy\u00e8re O. Malnutrition as a strong predictor of the onset of sarcopenia. Nutrients. 2019;11:2883.","DOI":"10.3390\/nu11122883"},{"key":"431_CR68","doi-asserted-by":"crossref","unstructured":"Maykish A, Sikalidis AK. Utilization of hydroxyl-methyl butyrate, leucine, glutamine and arginine supplementation in nutritional management of sarcopenia-implications and clinical considerations for type 2 diabetes mellitus risk modulation. J Pers Med. 2020;10:19.","DOI":"10.3390\/jpm10010019"},{"key":"431_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2022.109803","volume":"186","author":"S Low","year":"2022","unstructured":"Low S, Wang J, Moh A, Ang SF, Ang K, Shao YM, et al. Amino acid profile of skeletal muscle loss in type 2 diabetes: Results from a 7-year longitudinal study in asians. Diab Res Clin Pr. 2022;186:109803.","journal-title":"Diab Res Clin Pr"},{"key":"431_CR70","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.3389\/fendo.2023.1185221","volume":"14","author":"S Wei","year":"2023","unstructured":"Wei S, Nguyen TT, Zhang Y, Ryu D, Gariani K. Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and management. Front Endocrinol. 2023;14:2023.","journal-title":"Front Endocrinol"},{"key":"431_CR71","first-page":"693","volume":"11","author":"S Stenholm","year":"2008","unstructured":"Stenholm S, Harris TB, Rantanen T, Visser M, Kritchevsky SB, Ferrucci L. Sarcopenic obesity: definition, cause and consequences. Curr Opin Clin Nutr Metab Care. 2008;11:693\u2013700.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"431_CR72","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1159\/000521241","volume":"15","author":"LM Donini","year":"2022","unstructured":"Donini LM, Busetto L, Bischoff SC, Cederholm T, Ballesteros-Pomar MD, Batsis JA, et al. Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement. Obes Facts. 2022;15:321\u201335.","journal-title":"Obes Facts"},{"key":"431_CR73","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1111\/obr.12862","volume":"20","author":"RCR Meex","year":"2019","unstructured":"Meex RCR, Blaak EE, van Loon LJC. Lipotoxicity plays a key role in the development of both insulin resistance and muscle atrophy in patients with type 2 diabetes. Obes Rev. 2019;20:1205\u201317.","journal-title":"Obes Rev"},{"key":"431_CR74","doi-asserted-by":"publisher","first-page":"4240","DOI":"10.1096\/fj.201601125RRR","volume":"31","author":"A Armani","year":"2017","unstructured":"Armani A, Berry A, Cirulli F, Caprio M. Molecular mechanisms underlying metabolic syndrome: the expanding role of the adipocyte. FASEB J. 2017;31:4240\u201355.","journal-title":"FASEB J"},{"key":"431_CR75","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41387-022-00213-3","volume":"12","author":"F Vanweert","year":"2022","unstructured":"Vanweert F, Schrauwen P, Phielix E. Role of branched-chain amino acid metabolism in the pathogenesis of obesity and type 2 diabetes-related metabolic disturbances BCAA metabolism in type 2 diabetes. Nutr Diab. 2022;12:35.","journal-title":"Nutr Diab"},{"key":"431_CR76","first-page":"73","volume":"30","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Zeng X. Sarcopenic obesity and cardiovascular disease risk and mortality: a systematic review and meta-analysis. Anatol J Cardiol. 2025;30:73\u201382.","journal-title":"Anatol J Cardiol"},{"key":"431_CR77","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1177\/1747493018778713","volume":"13","author":"D Sacks","year":"2018","unstructured":"Sacks D, Baxter B, Campbell BCV, Carpenter JS, Cognard C, Dippel D, et al. Multisociety consensus quality improvement revised consensus statement for endovascular therapy of acute ischemic stroke. Int J Stroke. 2018;13:612\u201332.","journal-title":"Int J Stroke"},{"key":"431_CR78","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1186\/s13098-025-02032-9","volume":"17","author":"Y Xin","year":"2025","unstructured":"Xin Y, Qian X, Yang Y. Associations between sarcopenic obesity and the risk of cardiovascular-kidney-metabolic syndrome progression: insights from the China Health and Retirement Longitudinal Study. Diabetol Metab Syndr. 2025;17:460.","journal-title":"Diabetol Metab Syndr"},{"key":"431_CR79","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-025-06105-2","volume":"25","author":"K Silay","year":"2025","unstructured":"Silay K, Selvi Oztorun H. Sarcopenic obesity is linked to worse clinical outcomes than sarcopenia or obesity alone in hospitalized older adults. BMC Geriatr. 2025;25:443.","journal-title":"BMC Geriatr"},{"key":"431_CR80","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-10200-0","volume":"15","author":"P Zhang","year":"2025","unstructured":"Zhang P, Du Y, Zhong X, Wang Y, Pan T. Identification of potential shared core biomarkers in type 2 diabetes and sarcopenia. Sci Rep. 2025;15:25439.","journal-title":"Sci Rep"},{"key":"431_CR81","doi-asserted-by":"crossref","unstructured":"Massimino E, Izzo A, Riccardi G, Della Pepa G. The impact of glucose-lowering drugs on sarcopenia in type 2 diabetes: current evidence and underlying mechanisms. Cells. 2021;10:1958.","DOI":"10.3390\/cells10081958"},{"key":"431_CR82","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1038\/oby.2012.20","volume":"20","author":"ME Levine","year":"2012","unstructured":"Levine ME, Crimmins EM. The impact of insulin resistance and inflammation on the association between sarcopenic obesity and physical functioning. Obesity. 2012;20:2101\u20136.","journal-title":"Obesity"},{"key":"431_CR83","doi-asserted-by":"publisher","first-page":"8152","DOI":"10.1002\/jcp.27603","volume":"234","author":"H Yaribeygi","year":"2019","unstructured":"Yaribeygi H, Farrokhi FR, Butler AE, Sahebkar A. Insulin resistance: review of the underlying molecular mechanisms. J Cell Physiol. 2019;234:8152\u201361.","journal-title":"J Cell Physiol"},{"key":"431_CR84","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/dom.15321","volume":"26","author":"W Tack","year":"2024","unstructured":"Tack W, De Cock AM, Dirinck EL, Bastijns S, Ari\u00ebn F, Perkisas S. Pathophysiological interactions between sarcopenia and type 2 diabetes: A two-way street influencing diagnosis and therapeutic options. Diab Obes Metab. 2024;26:407\u201316.","journal-title":"Diab Obes Metab"},{"key":"431_CR85","doi-asserted-by":"publisher","first-page":"e10805","DOI":"10.1371\/journal.pone.0010805","volume":"5","author":"P Srikanthan","year":"2010","unstructured":"Srikanthan P, Hevener AL, Karlamangla AS. Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia: findings from the National Health and Nutrition Examination Survey III. PLoS One. 2010;5:e10805.","journal-title":"PLoS One"},{"key":"431_CR86","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1042\/CS20191320","volume":"134","author":"M Chen","year":"2020","unstructured":"Chen M, Ji C, Yang Q, Gao S, Peng Y, Li Z, et al. AKT2 regulates development and metabolic homeostasis via AMPK-depedent pathway in skeletal muscle. Clin Sci. 2020;134:2381\u201398.","journal-title":"Clin Sci"},{"key":"431_CR87","doi-asserted-by":"crossref","unstructured":"Nishikawa H, Fukunishi S, Asai A, Yokohama K, Ohama H, Nishiguchi S, et al. Sarcopenia, frailty and type 2 diabetes mellitus. Mol Med Rep. 2021;24:854.","DOI":"10.3892\/mmr.2021.12494"},{"key":"431_CR88","first-page":"115","volume":"37","author":"G D\u2019Antona","year":"2010","unstructured":"D\u2019Antona G, Nisoli E. mTOR signaling as a target of amino acid treatment of the age-related sarcopenia. Interdiscip Top Gerontol. 2010;37:115\u201341.","journal-title":"Interdiscip Top Gerontol"},{"key":"431_CR89","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1159\/000356740","volume":"60","author":"TA White","year":"2014","unstructured":"White TA, LeBrasseur NK. Myostatin and sarcopenia: opportunities and challenges\u2014a mini-review. Gerontology. 2014;60:289\u201393.","journal-title":"Gerontology"},{"key":"431_CR90","doi-asserted-by":"crossref","unstructured":"Godala M, Gaszy\u0144ska E, Walczak K, Ma\u0142ecka-Wojciesko E. Myostatin and activin A as biomarkers of sarcopenia in inflammatory bowel disease patients. Nutrients. 2024;16:810.","DOI":"10.3390\/nu16060810"},{"key":"431_CR91","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/bs.acc.2019.07.010","volume":"94","author":"M Gomarasca","year":"2020","unstructured":"Gomarasca M, Banfi G, Lombardi G. Myokines: the endocrine coupling of skeletal muscle and bone. Adv Clin Chem. 2020;94:155\u2013218.","journal-title":"Adv Clin Chem"},{"key":"431_CR92","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/s11914-020-00599-y","volume":"18","author":"B Kirk","year":"2020","unstructured":"Kirk B, Feehan J, Lombardi G, Duque G. Muscle, bone, and fat crosstalk: the biological role of myokines, osteokines, and adipokines. Curr Osteoporos Rep. 2020;18:388\u2013400.","journal-title":"Curr Osteoporos Rep"},{"key":"431_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122125","volume":"332","author":"N Muvhulawa","year":"2023","unstructured":"Muvhulawa N, Mazibuko-Mbeje SE, Ndwandwe D, Silvestri S, Ziqubu K, Moetlediwa MT, et al. Sarcopenia in a type 2 diabetic state: reviewing literature on the pathological consequences of oxidative stress and inflammation beyond the neutralizing effect of intracellular antioxidants. Life Sci. 2023;332:122125.","journal-title":"Life Sci"},{"key":"431_CR94","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13765-023-00767-5","volume":"66","author":"H-Y Lee","year":"2023","unstructured":"Lee H-Y, Kim J-S. Cherry fruit anthocyanins cyanidin-3-O-glucoside and cyanidin-3-O-rutinoside protect against blue light-induced cytotoxicity in HaCaT cells. Appl Biol Chem. 2023;66:3.","journal-title":"Appl Biol Chem"},{"key":"431_CR95","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1089\/ars.2019.7989","volume":"32","author":"M Waldman","year":"2020","unstructured":"Waldman M, Arad M, Abraham NG, Hochhauser E. The peroxisome proliferator-activated receptor-gamma coactivator-1\u03b1-heme oxygenase 1 axis, a powerful antioxidative pathway with potential to attenuate diabetic cardiomyopathy. Antioxid Redox Signal. 2020;32:1273\u201390.","journal-title":"Antioxid Redox Signal"},{"key":"431_CR96","doi-asserted-by":"publisher","first-page":"C1248","DOI":"10.1152\/ajpcell.00104.2009","volume":"296","author":"R Sartori","year":"2009","unstructured":"Sartori R, Milan G, Patron M, Mammucari C, Blaauw B, Abraham R, et al. Smad2 and 3 transcription factors control muscle mass in adulthood. Am J Physiol Cell Physiol. 2009;296:C1248\u201357.","journal-title":"Am J Physiol Cell Physiol"},{"key":"431_CR97","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1002\/jcsm.13241","volume":"14","author":"Q Zhong","year":"2023","unstructured":"Zhong Q, Zheng K, Li W, An K, Liu Y, Xiao X, et al. Post-translational regulation of muscle growth, muscle aging and sarcopenia. J Cachexia Sarcopenia Muscle. 2023;14:1212\u201327.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"431_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102267","volume":"96","author":"G Livshits","year":"2024","unstructured":"Livshits G, Kalinkovich A. Restoration of epigenetic impairment in the skeletal muscle and chronic inflammation resolution as a therapeutic approach in sarcopenia. Ageing Res Rev. 2024;96:102267.","journal-title":"Ageing Res Rev"},{"key":"431_CR99","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S1097-2765(04)00211-4","volume":"14","author":"TN Stitt","year":"2004","unstructured":"Stitt TN, Drujan D, Clarke BA, Panaro F, Timofeyva Y, Kline WO, et al. The IGF-1\/PI3K\/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell. 2004;14:395\u2013403.","journal-title":"Mol Cell"},{"key":"431_CR100","doi-asserted-by":"publisher","first-page":"E469","DOI":"10.1152\/ajpendo.00204.2014","volume":"307","author":"SC Bodine","year":"2014","unstructured":"Bodine SC, Baehr LM. Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx\/atrogin-1. Am J Physiol Endocrinol Metab. 2014;307:E469\u201384.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"431_CR101","doi-asserted-by":"crossref","unstructured":"Pickering AM, Miller RA. Immunoproteasome system in aging, lifespan, and age-associated disease. In: Fulop T, Franceschi C, Hirokawa K, Pawelec G, editors. Handbook of Immunosenescence: basic understanding and clinical implications. Cham: Springer International Publishing; 2019. p. 1281\u201397.","DOI":"10.1007\/978-3-319-99375-1_111"},{"key":"431_CR102","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/5716409","volume":"2017","author":"AL Santos","year":"2017","unstructured":"Santos AL, Lindner AB. Protein posttranslational modifications: roles in aging and age-related disease. Oxid Med Cell Longev. 2017;2017:5716409.","journal-title":"Oxid Med Cell Longev"},{"key":"431_CR103","doi-asserted-by":"crossref","unstructured":"Sanz-C\u00e1novas J, L\u00f3pez-Sampalo A, Cobos-Palacios L, Ricci M, Hern\u00e1ndez-Negr\u00edn H, Mancebo-Sevilla JJ, et al. Management of type 2 diabetes mellitus in elderly patients with frailty and\/or sarcopenia. Int J Environ Res Public Health. 2022;19:8677.","DOI":"10.3390\/ijerph19148677"},{"key":"431_CR104","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.molcel.2017.04.007","volume":"66","author":"ZX Meng","year":"2017","unstructured":"Meng ZX, Gong J, Chen Z, Sun J, Xiao Y, Wang L, et al. Glucose sensing by skeletal myocytes couples nutrient signaling to systemic homeostasis. Mol Cell. 2017;66:332\u201344.e4.","journal-title":"Mol Cell"},{"key":"431_CR105","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1002\/ejhf.2011","volume":"22","author":"A Bielecka-Dabrowa","year":"2020","unstructured":"Bielecka-Dabrowa A, Ebner N, Dos Santos MR, Ishida J, Hasenfuss G, von Haehling S. Cachexia, muscle wasting, and frailty in cardiovascular disease. Eur J Heart Fail. 2020;22:2314\u201326.","journal-title":"Eur J Heart Fail"},{"key":"431_CR106","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.jjcc.2021.10.013","volume":"79","author":"KI Sasaki","year":"2022","unstructured":"Sasaki KI, Fukumoto Y. Sarcopenia as a comorbidity of cardiovascular disease. J Cardiol. 2022;79:596\u2013604.","journal-title":"J Cardiol"},{"key":"431_CR107","doi-asserted-by":"crossref","unstructured":"Izzo A, Massimino E, Riccardi G, Della Pepa G. A narrative review on sarcopenia in type 2 diabetes mellitus: prevalence and associated factors. Nutrients. 2021;13:183.","DOI":"10.3390\/nu13010183"},{"key":"431_CR108","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.jocd.2015.04.010","volume":"18","author":"MH Edwards","year":"2015","unstructured":"Edwards MH, Buehring B. Novel approaches to the diagnosis of sarcopenia. J Clin Densitom. 2015;18:472\u20137.","journal-title":"J Clin Densitom"},{"key":"431_CR109","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1083722","volume":"14","author":"L Lu","year":"2023","unstructured":"Lu L, Liu B, Yin F. Alternative skeletal muscle index for sarcopenia diagnosis in elderly patients with type 2 diabetes mellitus: a pilot study. Front Endocrinol. 2023;14:1083722.","journal-title":"Front Endocrinol"},{"key":"431_CR110","first-page":"181","volume":"11","author":"G Rubbieri","year":"2014","unstructured":"Rubbieri G, Mossello E, Di Bari M. Techniques for the diagnosis of sarcopenia. Clin Cases Min Bone Metab. 2014;11:181\u20134.","journal-title":"Clin Cases Min Bone Metab"},{"key":"431_CR111","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1007\/s00261-021-03294-3","volume":"47","author":"V Chianca","year":"2022","unstructured":"Chianca V, Albano D, Messina C, Gitto S, Ruffo G, Guarino S, et al. Sarcopenia: imaging assessment and clinical application. Abdom Radio. 2022;47:3205\u201316.","journal-title":"Abdom Radio"},{"key":"431_CR112","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1007\/s00330-019-06573-2","volume":"30","author":"D Albano","year":"2020","unstructured":"Albano D, Messina C, Vitale J, Sconfienza LM. Imaging of sarcopenia: old evidence and new insights. Eur Radio. 2020;30:2199\u2013208.","journal-title":"Eur Radio"},{"key":"431_CR113","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101576","volume":"76","author":"JC Liu","year":"2022","unstructured":"Liu JC, Dong SS, Shen H, Yang DY, Chen BB, Ma XY, et al. Multi-omics research in sarcopenia: Current progress and future prospects. Ageing Res Rev. 2022;76:101576.","journal-title":"Ageing Res Rev"},{"key":"431_CR114","first-page":"38","volume":"23","author":"JH Lo","year":"2020","unstructured":"Lo JH, U KP, Yiu T, Ong MT, Lee WY. Sarcopenia: current treatments and new regenerative therapeutic approaches. J Orthop Transl. 2020;23:38\u201352.","journal-title":"J Orthop Transl"},{"key":"431_CR115","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/s40200-023-01262-w","volume":"22","author":"N Johri","year":"2023","unstructured":"Johri N, Vengat M, Kumar D, Nagar P, John D, Dutta S, et al. A comprehensive review on the risks assessment and treatment options for Sarcopenia in people with diabetes. J Diab Metab Disord. 2023;22:995\u20131010.","journal-title":"J Diab Metab Disord"},{"key":"431_CR116","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s40266-023-01042-4","volume":"40","author":"MD Witham","year":"2023","unstructured":"Witham MD, Granic A, Pearson E, Robinson SM, Sayer AA. Repurposing drugs for diabetes mellitus as potential pharmacological treatments for sarcopenia\u2014a narrative review. Drugs Aging. 2023;40:703\u201319.","journal-title":"Drugs Aging"},{"key":"431_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2024.102998","volume":"55","author":"R Qaisar","year":"2024","unstructured":"Qaisar R, Karim A, Muhammad T, Iqbal MS, Ahmad F. Metformin improves sarcopenia-related quality of life in geriatric adults: a randomized controlled trial. Arch Med Res. 2024;55:102998.","journal-title":"Arch Med Res"},{"key":"431_CR118","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12933-023-01798-4","volume":"22","author":"P Gourdy","year":"2023","unstructured":"Gourdy P, Darmon P, Dievart F, Halimi JM, Guerci B. Combining glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) in patients with type 2 diabetes mellitus (T2DM). Cardiovasc Diabetol. 2023;22:79.","journal-title":"Cardiovasc Diabetol"},{"key":"431_CR119","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1080\/14656566.2019.1622093","volume":"20","author":"JP Hardee","year":"2019","unstructured":"Hardee JP, Lynch GS. Current pharmacotherapies for sarcopenia. Expert Opin Pharmacother. 2019;20:1645\u201357.","journal-title":"Expert Opin Pharmacother"},{"key":"431_CR120","first-page":"25","volume":"78","author":"S Bhasin","year":"2023","unstructured":"Bhasin S, Krishnan V, Storer TW, Steiner M, Dobs AS. Androgens and selective androgen receptor modulators to treat functional limitations associated with aging and chronic disease. J Gerontology: Ser A. 2023;78:25\u201331.","journal-title":"J Gerontology: Ser A"},{"key":"431_CR121","doi-asserted-by":"publisher","first-page":"719","DOI":"10.4093\/dmj.2023.0112","volume":"47","author":"J Mesinovic","year":"2023","unstructured":"Mesinovic J, Fyfe JJ, Talevski J, Wheeler MJ, Leung GKW, George ES, et al. Type 2 diabetes mellitus and sarcopenia as comorbid chronic diseases in older adults: established and emerging treatments and therapies. Diab Metab J. 2023;47:719\u201342.","journal-title":"Diab Metab J"},{"key":"431_CR122","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1002\/jcsm.12639","volume":"11","author":"D Rooks","year":"2020","unstructured":"Rooks D, Petricoul O, Praestgaard J, Bartlett M, Laurent D, Roubenoff R. Safety and pharmacokinetics of bimagrumab in healthy older and obese adults with body composition changes in the older cohort. J Cachexia Sarcopenia Muscle. 2020;11:1525\u201334.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"431_CR123","doi-asserted-by":"publisher","first-page":"98","DOI":"10.4235\/agmr.19.0028","volume":"23","author":"JY Kwak","year":"2019","unstructured":"Kwak JY, Kwon KS. Pharmacological interventions for treatment of sarcopenia: current status of drug development for sarcopenia. Ann Geriatr Med Res. 2019;23:98\u2013104.","journal-title":"Ann Geriatr Med Res"},{"key":"431_CR124","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1002\/jcsm.12838","volume":"12","author":"X Zhang","year":"2021","unstructured":"Zhang X, Zhao Y, Chen S, Shao H. Anti-diabetic drugs and sarcopenia: emerging links, mechanistic insights, and clinical implications. J Cachexia, Sarcopenia Muscle. 2021;12:1368\u201379.","journal-title":"J Cachexia, Sarcopenia Muscle"},{"key":"431_CR125","doi-asserted-by":"crossref","unstructured":"Witham MD, McDonald C, Wilson N, Rennie KJ, Bardgett M, Bradley P, et al. Metformin and physical performance in older people with probable sarcopenia and physical prefrailty or frailty in England (MET-PREVENT): a double-blind, randomised, placebo-controlled trial. Lancet Healthy Longev. 2025;6:100695.","DOI":"10.1016\/j.lanhl.2025.100695"},{"key":"431_CR126","volume":"2020","author":"Q He","year":"2020","unstructured":"He Q, Wang X, Yang C, Zhuang X, Yue Y, Jing H, et al. Metabolic and nutritional characteristics in middle-aged and elderly sarcopenia patients with type 2 diabetes. J Diab Res. 2020;2020:6973469.","journal-title":"J Diab Res"},{"key":"431_CR127","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/jcsm.12043","volume":"6","author":"TS Bowen","year":"2015","unstructured":"Bowen TS, Schuler G, Adams V. Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training. J Cachexia Sarcopenia Muscle. 2015;6:197\u2013207.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"431_CR128","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2023.155711","volume":"149","author":"Aslam MA","year":"2023","unstructured":"Aslam MA, Ma EB, Huh JY. Pathophysiology of sarcopenia: genetic factors and their interplay with environmental factors. Metabolism. 2023;149:155711.","journal-title":"Metabolism"},{"key":"431_CR129","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1093\/hmg\/ddv613","volume":"25","author":"MW Hogarth","year":"2015","unstructured":"Hogarth MW, Garton FC, Houweling PJ, Tukiainen T, Lek M, Macarthur DG, et al. Analysis of the ACTN3 heterozygous genotype suggests that \u03b1-actinin-3 controls sarcomeric composition and muscle function in a dose-dependent fashion. Hum Mol Genet. 2015;25:866\u201377.","journal-title":"Hum Mol Genet"},{"key":"431_CR130","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1249\/MSS.0b013e318161eab9","volume":"40","author":"DE Charbonneau","year":"2008","unstructured":"Charbonneau DE, Hanson ED, Ludlow AT, Delmonico MJ, Hurley BF, Roth SM. ACE genotype and the muscle hypertrophic and strength responses to strength training. Med Sci Sports Exerc. 2008;40:677\u201383.","journal-title":"Med Sci Sports Exerc"},{"key":"431_CR131","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/hr.2016.28","volume":"39","author":"D Motta-Santos","year":"2016","unstructured":"Motta-Santos D, dos Santos RAS, Oliveira M, Qadri F, Poglitsch M, Mosienko V, et al. Effects of ACE2 deficiency on physical performance and physiological adaptations of cardiac and skeletal muscle to exercise. Hypertens Res. 2016;39:506\u201312.","journal-title":"Hypertens Res"},{"key":"431_CR132","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/S1043-2760(00)00310-6","volume":"11","author":"DR Woods","year":"2000","unstructured":"Woods DR, Humphries SE, Montgomery HE. The ACE I\/D polymorphism and human physical performance. Trends Endocrinol Metab. 2000;11:416\u201320.","journal-title":"Trends Endocrinol Metab"},{"key":"431_CR133","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1194\/jlr.M400486-JLR200","volume":"46","author":"RM Lane","year":"2005","unstructured":"Lane RM, Farlow MR. Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease. J Lipid Res. 2005;46:949\u201368.","journal-title":"J Lipid Res"},{"key":"431_CR134","doi-asserted-by":"crossref","unstructured":"Florczak-Wyspia\u0144ska J, Hur\u0142a M, Pikor D, Poszwa J, Korczowska-\u0141\u0105cka I, Szymanowicz O, et al. The APOE gene cluster in normal aging. J Integr Neurosci. 2025;24:36401.","DOI":"10.31083\/JIN36401"},{"key":"431_CR135","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13048","volume":"18","author":"AA Johnson","year":"2019","unstructured":"Johnson AA, Stolzing A. The role of lipid metabolism in aging, lifespan regulation, and age-related disease. Aging Cell. 2019;18:e13048.","journal-title":"Aging Cell"},{"key":"431_CR136","doi-asserted-by":"crossref","unstructured":"Pradhan BS, Pr\u00f3szy\u0144ski TJ. A role for caveolin-3 in the pathogenesis of muscular dystrophies. Int J Mol Sci. 2020;21:8736.","DOI":"10.3390\/ijms21228736"},{"key":"431_CR137","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/ejhg.2009.103","volume":"18","author":"E Gazzerro","year":"2010","unstructured":"Gazzerro E, Sotgia F, Bruno C, Lisanti MP, Minetti C. Caveolinopathies: from the biology of caveolin-3 to human diseases. Eur J Hum Genet. 2010;18:137\u201345.","journal-title":"Eur J Hum Genet"},{"key":"431_CR138","doi-asserted-by":"publisher","DOI":"10.1111\/acel.14413","volume":"24","author":"C Soendenbroe","year":"2025","unstructured":"Soendenbroe C, Schjerling P, Bechsh\u00f8ft CJL, Svensson RB, Schaeffer L, Kjaer M, et al. Muscle fibroblasts and stem cells stimulate motor neurons in an age and exercise-dependent manner. Aging Cell. 2025;24:e14413.","journal-title":"Aging Cell"},{"key":"431_CR139","doi-asserted-by":"crossref","unstructured":"Stanga S, Boido M, Kienlen-Campard P. How to build and to protect the neuromuscular junction: the role of the glial cell line-derived neurotrophic factor. Int J Mol Sci. 2020;22:136.","DOI":"10.3390\/ijms22010136"},{"key":"431_CR140","doi-asserted-by":"publisher","first-page":"101293","DOI":"10.1016\/j.ijcha.2023.101293","volume":"49","author":"A Samii","year":"2023","unstructured":"Samii A, Aslani S, Imani D, Razi B, Samaneh Tabaee S, Jamialahmadi T, et al. MTHFR gene polymorphisms and susceptibility to myocardial infarction: evidence from meta-analysis and trial sequential analysis. IJC Heart Vasc. 2023;49:101293.","journal-title":"IJC Heart Vasc"},{"key":"431_CR141","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1515\/hukin-2015-0171","volume":"51","author":"N Din\u00e7","year":"2016","unstructured":"Din\u00e7 N, Y\u00fccel SB, Taneli F, Say\u0131n MV. The effect of the MTHFR C677T mutation on athletic performance and the homocysteine level of soccer players and sedentary individuals. J Hum Kinet. 2016;51:61\u20139.","journal-title":"J Hum Kinet"},{"key":"431_CR142","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.freeradbiomed.2015.05.036","volume":"88","author":"H Zhang","year":"2015","unstructured":"Zhang H, Davies KJA, Forman HJ. Oxidative stress response and Nrf2 signaling in aging. Free Radic Biol Med. 2015;88:314\u201336.","journal-title":"Free Radic Biol Med"},{"key":"431_CR143","doi-asserted-by":"crossref","unstructured":"Ngo V, Duennwald ML. Nrf2 and oxidative stress: a general overview of mechanisms and implications in human disease. Antioxidants. 2022;11:2345.","DOI":"10.3390\/antiox11122345"},{"key":"431_CR144","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6635460","volume":"2021","author":"C Yu","year":"2021","unstructured":"Yu C, Xiao J-H. The Keap1-Nrf2 system: a mediator between oxidative stress and aging. Oxid Med Cell Longev. 2021;2021:6635460.","journal-title":"Oxid Med Cell Longev"},{"key":"431_CR145","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.876078","volume":"13","author":"MH Baig","year":"2022","unstructured":"Baig MH, Ahmad K, Moon JS, Park SY, Ho Lim J, Chun HJ, et al. Myostatin and its regulation: a comprehensive review of myostatin inhibiting strategies. Front Physiol. 2022;13:876078.","journal-title":"Front Physiol"},{"key":"431_CR146","doi-asserted-by":"publisher","DOI":"10.1002\/cbf.4106","volume":"42","author":"S Sharma","year":"2024","unstructured":"Sharma S, Patil AS. Myostatin's marvels: from muscle regulator to diverse implications in health and disease. Cell Biochem Funct. 2024;42:e4106.","journal-title":"Cell Biochem Funct"},{"key":"431_CR147","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s44162-025-00086-x","volume":"4","author":"G Dewasi","year":"2025","unstructured":"Dewasi G, Nagda P, Bahl G, Jain V, Gupta SK. Myostatin-driven muscle hypertrophy: a double-edged sword in muscle physiology. J Rare Dis. 2025;4:29.","journal-title":"J Rare Dis"},{"key":"431_CR148","doi-asserted-by":"crossref","unstructured":"Yoshida T, Delafontaine P. Mechanisms of IGF-1-mediated regulation of skeletal muscle hypertrophy and atrophy. Cells. 2020;9:1970.","DOI":"10.3390\/cells9091970"},{"key":"431_CR149","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12954","volume":"18","author":"F Ascenzi","year":"2019","unstructured":"Ascenzi F, Barberi L, Dobrowolny G, Villa Nova Bacurau A, Nicoletti C, Rizzuto E, et al. Effects of IGF-1 isoforms on muscle growth and sarcopenia. Aging Cell. 2019;18:e12954.","journal-title":"Aging Cell"},{"key":"431_CR150","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1210\/endrev\/bnaf041","volume":"47","author":"S Bhasin","year":"2025","unstructured":"Bhasin S, Wang C, Chandra MS, Gagliano-Juc\u00e1 T, Jasuja R. Mechanisms of testosterone's anabolic effects on muscle and function: controversies and new insights. Endocr Rev. 2025;47:280\u2013300.","journal-title":"Endocr Rev"},{"key":"431_CR151","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2020.154347","volume":"112","author":"R Kruse","year":"2020","unstructured":"Kruse R, Petersson SJ, Christensen LL, Kristensen JM, Sabaratnam R, \u00d8rtenblad N, et al. Effect of long-term testosterone therapy on molecular regulators of skeletal muscle mass and fibre-type distribution in aging men with subnormal testosterone. Metabolism. 2020;112:154347.","journal-title":"Metabolism"},{"key":"431_CR152","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.molmed.2013.04.004","volume":"19","author":"M L\u00f3pez","year":"2013","unstructured":"L\u00f3pez M, Alvarez CV, Nogueiras R, Di\u00e9guez C. Energy balance regulation by thyroid hormones at central level. Trends Mol Med. 2013;19:418\u201327.","journal-title":"Trends Mol Med"},{"key":"431_CR153","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1210\/js.2018-00423","volume":"3","author":"S Yavuz","year":"2019","unstructured":"Yavuz S, Salgado Nunez del Prado S, Celi FS. Thyroid hormone action and energy expenditure. J Endocr Soc. 2019;3:1345\u201356.","journal-title":"J Endocr Soc"},{"key":"431_CR154","doi-asserted-by":"crossref","unstructured":"Du XL, Xu WJ, Shi JL, Guo K, Guo CT, Zheng R, et al. Glucocorticoid receptor alpha targets SLC2A4 to regulate protein synthesis and breakdown in porcine skeletal muscle cells. Biomolecules. 2021;11:721.","DOI":"10.3390\/biom11050721"},{"key":"431_CR155","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2024.102078","volume":"91","author":"R Asgari","year":"2025","unstructured":"Asgari R, Caceres-Valdiviezo M, Wu S, Hamel L, Humber BE, Agarwal SM, et al. Regulation of energy balance by leptin as an adiposity signal and modulator of the reward system. Mol Metab. 2025;91:102078.","journal-title":"Mol Metab"},{"key":"431_CR156","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.3389\/fphys.2022.1054107","volume":"13","author":"H Chen","year":"2022","unstructured":"Chen H, Zhang H, Jia T, Wang Z, Zhu W. Roles of leptin on energy balance and thermoregulation in Eothenomys miletus. Front Physiol. 2022;13:2022.","journal-title":"Front Physiol"},{"key":"431_CR157","doi-asserted-by":"crossref","unstructured":"Begum M, Choubey M, Tirumalasetty MB, Arbee S, Mohib MM, Wahiduzzaman M, et al. Adiponectin: a promising target for the treatment of diabetes and its complications. Life. 2023;13:2213.","DOI":"10.3390\/life13112213"},{"key":"431_CR158","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1093\/jmcb\/mjw012","volume":"8","author":"Y Luo","year":"2016","unstructured":"Luo Y, Liu M. Adiponectin: a versatile player of innate immunity. J Mol Cell Biol. 2016;8:120\u20138.","journal-title":"J Mol Cell Biol"},{"key":"431_CR159","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/jmcb\/mjw014","volume":"8","author":"H Ruan","year":"2016","unstructured":"Ruan H, Dong LQ. Adiponectin signaling and function in insulin target tissues. J Mol Cell Biol. 2016;8:101\u20139.","journal-title":"J Mol Cell Biol"},{"key":"431_CR160","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/jcsm.13141","volume":"14","author":"M Guo","year":"2023","unstructured":"Guo M, Yao J, Li J, Zhang J, Wang D, Zuo H, et al. Irisin ameliorates age-associated sarcopenia and metabolic dysfunction. J Cachexia Sarcopenia Muscle. 2023;14:391\u2013405.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"431_CR161","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101680","volume":"80","author":"H Zhang","year":"2022","unstructured":"Zhang H, Wu X, Liang J, Kirberger M, Chen N. Irisin, an exercise-induced bioactive peptide beneficial for health promotion during aging process. Ageing Res Rev. 2022;80:101680.","journal-title":"Ageing Res Rev"},{"key":"431_CR162","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01131-0","volume":"8","author":"MM Reza","year":"2017","unstructured":"Reza MM, Subramaniyam N, Sim CM, Ge X, Sathiakumar D, McFarlane C, et al. Irisin is a pro-myogenic factor that induces skeletal muscle hypertrophy and rescues denervation-induced atrophy. Nat Commun. 2017;8:1104.","journal-title":"Nat Commun"},{"key":"431_CR163","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/cbf.3595","volume":"39","author":"SE Bollen","year":"2021","unstructured":"Bollen SE, Atherton PJ. Myogenic, genomic and non-genomic influences of the vitamin D axis in skeletal muscle. Cell Biochem Funct. 2021;39:48\u201359.","journal-title":"Cell Biochem Funct"},{"key":"431_CR164","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-65067-0","volume":"10","author":"R Srikuea","year":"2020","unstructured":"Srikuea R, Hirunsai M, Charoenphandhu N. Regulation of vitamin D system in skeletal muscle and resident myogenic stem cell during development, maturation, and ageing. Sci Rep. 2020;10:8239.","journal-title":"Sci Rep"},{"key":"431_CR165","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2022.110355","volume":"96","author":"SE Bollen","year":"2022","unstructured":"Bollen SE, Bass JJ, Fujita S, Wilkinson D, Hewison M, Atherton PJ. The Vitamin D\/Vitamin D receptor (VDR) axis in muscle atrophy and sarcopenia. Cell Signal. 2022;96:110355.","journal-title":"Cell Signal"},{"key":"431_CR166","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41514-025-00326-w","volume":"12","author":"H Bozkir","year":"2026","unstructured":"Bozkir H, Brandt A, Csarmann K, Baumann A, Burger K, Yergaliyev T, et al. TNF\u03b1 is a trigger of aging-associated liver inflammation in mice. NPJ Aging. 2026;12:27.","journal-title":"NPJ Aging"},{"key":"431_CR167","first-page":"94","volume":"10","author":"J Wang","year":"2017","unstructured":"Wang J, Leung K-S, Chow SK-H, Cheung W-H. Inflammation and age-associated skeletal muscle deterioration (sarcopaenia). J Orthop Transl. 2017;10:94\u2013101.","journal-title":"J Orthop Transl"},{"key":"431_CR168","doi-asserted-by":"publisher","DOI":"10.1186\/2044-5040-2-2","volume":"2","author":"J De Larichaudy","year":"2012","unstructured":"De Larichaudy J, Zufferli A, Serra F, Isidori AM, Naro F, Dessalle K, et al. TNF-\u03b1- and tumor-induced skeletal muscle atrophy involves sphingolipid metabolism. Skelet Muscle. 2012;2:2.","journal-title":"Skelet Muscle"},{"key":"431_CR169","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-022-00893-8","volume":"27","author":"Z Tong","year":"2022","unstructured":"Tong Z, Yang X, Li J. Research progress on the mechanism of interleukin-1\u03b2 on epiphyseal plate chondrocytes. Eur J Med Res. 2022;27:313.","journal-title":"Eur J Med Res"},{"key":"431_CR170","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-94565-y","volume":"11","author":"WW Cheung","year":"2021","unstructured":"Cheung WW, Zheng R, Hao S, Wang Z, Gonzalez A, Zhou P, et al. The role of IL-1 in adipose browning and muscle wasting in CKD-associated cachexia. Sci Rep. 2021;11:15141.","journal-title":"Sci Rep"},{"key":"431_CR171","first-page":"2023","volume":"ume 14","author":"H Tu","year":"2023","unstructured":"Tu H, Li Y-L. Inflammation balance in skeletal muscle damage and repair. Front Immunol. 2023;ume 14:2023.","journal-title":"Front Immunol"},{"key":"431_CR172","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2024.2384664","volume":"56","author":"J Ding","year":"2024","unstructured":"Ding J, Yang G, Sun W, Li Y, Wang N, Wang J, et al. Association of interleukin-6 with sarcopenia and its components in older adults: a systematic review and meta-analysis of cross-sectional studies. Ann Med. 2024;56:2384664.","journal-title":"Ann Med"},{"key":"431_CR173","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.3389\/fimmu.2024.1330386","volume":"15","author":"A Tylutka","year":"2024","unstructured":"Tylutka A, Walas \u0141, Zembron-Lacny A. Level of IL-6, TNF, and IL-1\u03b2 and age-related diseases: a systematic review and meta-analysis. Front Immunol. 2024;15:2024.","journal-title":"Front Immunol"},{"key":"431_CR174","doi-asserted-by":"publisher","DOI":"10.1016\/j.archger.2020.104131","volume":"90","author":"C Custodero","year":"2020","unstructured":"Custodero C, Anton SD, Beavers DP, Mankowski RT, Lee SA, McDermott MM, et al. The relationship between interleukin-6 levels and physical performance in mobility-limited older adults with chronic low-grade inflammation: the ENRGISE Pilot study. Arch Gerontol Geriatr. 2020;90:104131.","journal-title":"Arch Gerontol Geriatr"},{"key":"431_CR175","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s11658-023-00439-8","volume":"28","author":"S Zhuang","year":"2023","unstructured":"Zhuang S, Russell A, Guo Y, Xu Y, Xiao W. IFN-\u03b3 blockade after genetic inhibition of PD-1 aggravates skeletal muscle damage and impairs skeletal muscle regeneration. Cell Mol Biol Lett. 2023;28:27.","journal-title":"Cell Mol Biol Lett"},{"key":"431_CR176","doi-asserted-by":"crossref","unstructured":"V\u00e1zquez-Del Mercado M, Mart\u00edn-M\u00e1rquez BT, Mart\u00ednez-Garc\u00eda EA, Petri MH. IFN-\u03b3 +874 T\/A is associated with high levels of Sera CPK in patients with inflammatory myopathies. Curr Issues Mol Biol. 2025;47:492.","DOI":"10.3390\/cimb47070492"},{"key":"431_CR177","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49460-1","volume":"15","author":"C Abad","year":"2024","unstructured":"Abad C, Pinal-Fernandez I, Guillou C, Bourdenet G, Drouot L, Cosette P, et al. IFN\u03b3 causes mitochondrial dysfunction and oxidative stress in myositis. Nat Commun. 2024;15:5403.","journal-title":"Nat Commun"}],"container-title":["Nutrition &amp; Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41387-026-00431-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41387-026-00431-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41387-026-00431-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T13:06:05Z","timestamp":1782479165000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41387-026-00431-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,4]]},"references-count":177,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["431"],"URL":"https:\/\/doi.org\/10.1038\/s41387-026-00431-z","relation":{},"ISSN":["2044-4052"],"issn-type":[{"value":"2044-4052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,4]]},"assertion":[{"value":"11 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18"}}